Innovations in Gene Delivery Platform Technology

USD 250.00

* Required Fields

USD 250.00

PAY BY INVOICE

Be the first to review this product

This edition of the Genetic Technology TOE depicts the current landscape and the new life sciences trends across gene delivery platform technologies. Since immuno-oncology and rare diseases are the most focused therapeutic areas in recent times, the TOE highlights recent innovations in these fields. The corresponding clinical trials scenario is also depicted.The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments

Table of Contents

Innovations in Gene Delivery Platform TechnologyRecent Advances in Gene Delivery Platform TechnologyGenetically Modified Probiotic Bacteria for Immuno-oncologyAdeno-associated Virus Gene Therapy Platform Non-viral Gene Delivery Platform Technology Hematopoietic Stem Cells to Target Specific Anti-tumor Proteins Clinical Trial Analysis and Key ContactsClinical Trial Analysis of Gene Delivery TherapiesKey Contacts




Keyword1

Keyword2

Keyword3

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.